Author
The author works as a Correspondent with BW Businessworld
In an exclusive conversation with Shivam Tyagi, BW Healthcare World, Krishnan Ramachandran, MD and CEO of Niva Bupa Health Insurance speaks on the growth of health insurance sector in the year 2022, outlook for 2023, finding the missing middle, trust deficit between hospitals and insurers and bringing on more services under the standard health insurance policies
Read More
Stressing the surging healthcare inflation, Bishen, said that healthcare costs are out of control and it's not just a pain in the US but all around the globe. “The US is close to USD 5 trillion out of the USD 12 trillion in terms of the overall healthcare spending globally, which has gone from eight and half trillion in 2018 to 12 trillion in 2022.”
Read More
In an interaction with BW Healthcare World, Dr Vikas Gupta, India Business Rx Head, Cipla speaks on the causes of the increasing asthma burden of India, its solutions, stigmas, challenges and awareness and management of the disease
Read More
India’s home healthcare market is poised to expand exponentially, thanks to the growing use of technology in healthcare management as well as significant cost benefits that homecare brings
Read More
Yadav highlighted the government and the private sector needs to spend more on the healthcare industry
Read More
A 2022 study published in the scientific journal Proceedings of the National Academy of Sciences has indicated that the recurrence of an extreme event like the Covid 19 pandemic has significantly tripled over the last 400 years
Read More
As per a 2021 report by the RSBA Advisors, the healthtech industry was valued at USD 1.9 billion in 2020 and is now poised to touch USD 5 billion by the year 2023 growing at a CAGR of 39 percent. The report expects the sector has the potential to grow to USD 50 billion industry in the coming 10 to 12 years
Read More
The top US regulator inspected Sun Pharma's Halol facility between April 26 to May 09 in 2022 and found adulterations in drugs. The samples collected for inspection of the drug offered for import in the US and mentioned as (b)(4) capsules in the warning letter failed to meet the specification for dissolution implying that the drug is adulterated, the USFDA said
Read More
IMA wants the government to rethink its planning of the integration of all systems of medicine by 2030. We would like that a thorough discussion should be held on understanding the impact of Mixopathy on our masses in consultation with IMA
Read More
Ideally, India should be spending at least 2.5- 3 per cent of its Gross Domestic Product on the healthcare system. Sadly, it does not. The healthcare sector and bodies affiliated with it have once again big expectations from the upcoming Union Budget
Read More
